APOF
Apolipoprotein F
Also known as: APOF_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q13790
- Gene
- APOF
- Ensembl
- ENSG00000175336
- Chromosome
- 12
- Canonical length
- 326 aa
- Protein class
- Plasma proteins, Predicted secreted proteins
- Secretome location
- Secreted to blood
OverviewNCBI Gene
The product of this gene is one of the minor apolipoproteins found in plasma. This protein forms complexes with lipoproteins and may be involved in transport and/or esterification of cholesterol. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
326 residues, UniProt reviewed canonical sequence.
>Q13790|APOF
1 MTGLCGYSAP DMRGLRLIMI PVELLLCYLL LHPVDATSYG KQTNVLMHFP LSLESQTPSS
61 DPLSCQFLHP KSLPGFSHMA PLPKFLVSLA LRNALEEAGC QADVWALQLQ LYRQGGVNAT
121 QVLIQHLRGL QKGRSTERNV SVEALASALQ LLAREQQSTG RVGRSLPTED CENEKEQAVH
181 NVVQLLPGVG TFYNLGTALY YATQNCLGKA RERGRDGAID LGYDLLMTMA GMSGGPMGLA
241 ISAALKPALR SGVQQLIQYY QDQKDANISQ PETTKEGLRA ISDVSDLEET TTLASFISEV
301 VSSAPYWGWA IIKSYDLDPG AGSLEILocalizationUniProt · AlphaFold · HPA
Whether an antibody against APOF can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.46
- Highest tissue expression
- 389 nTPM
Expression across tissuesHPA
Tissue
- liver: 389 nTPM
- prostate: 1.1 nTPM
- retina: 0.3 nTPM
- bone marrow: 0.2 nTPM
- testis: 0.2 nTPM
- appendix: 0.1 nTPM
Single-cell type
- hepatocytes: 347 nCPM
- kupffer cells: 11 nCPM
- cholangiocytes: 6.6 nCPM
- prostatic glandular cells: 2.1 nCPM
- b-cells: 2 nCPM
- cardiomyocytes: 1.6 nCPM
Immune cell
- basophil: 0.3 nTPM
- naive B-cell: 0.3 nTPM
- memory B-cell: 0.2 nTPM
- naive CD4 T-cell: 0.2 nTPM
- neutrophil: 0.2 nTPM
- MAIT T-cell: 0.1 nTPM
Brain region
- white matter: 4.1 nTPM
- cerebellum: 3.5 nTPM
- basal ganglia: 2.7 nTPM
- cerebral cortex: 2.7 nTPM
- medulla oblongata: 2.7 nTPM
- pons: 2.6 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.23
- gnomAD pLI
- 0.01
- gnomAD missense Z
- 0.35
- DepMap mean gene effect
- -0.06
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cholesterol efflux
- cholesterol metabolic process
- lipid metabolic process
- lipid transport
- triglyceride metabolic process
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Apolipoprotein F
- Apolipoprotein F
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads APOF as an antibody target. Whether an autoantibody or antibody against APOF could matter depends on whether native APOF is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
APOF is annotated as secreted, so native APOF circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label APOF as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...